Annual Current Assets
$15.54 M
-$18.99 M-54.99%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual total current assets is $15.54 million, with the most recent change of -$18.99 million (-54.99%) on December 31, 2023.
- During the last 3 years, MTNB annual current assets has fallen by -$46.01 million (-74.75%).
- MTNB annual current assets is now -74.75% below its all-time high of $61.55 million, reached on December 31, 2020.
Performance
MTNB Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$11.74 M
-$3.54 M-23.19%
September 30, 2024
Summary
- As of February 7, 2025, MTNB quarterly total current assets is $11.74 million, with the most recent change of -$3.54 million (-23.19%) on September 30, 2024.
- Over the past year, MTNB quarterly current assets has dropped by -$8.25 million (-41.26%).
- MTNB quarterly current assets is now -84.13% below its all-time high of $73.99 million, reached on March 31, 2020.
Performance
MTNB Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
MTNB Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -55.0% | -41.3% |
3 y3 years | -74.8% | -41.3% |
5 y5 years | +18.8% | -41.3% |
MTNB Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -69.5% | at low | -77.0% | +14.1% |
5 y | 5-year | -74.8% | at low | -84.1% | +14.1% |
alltime | all time | -74.8% | +454.1% | -84.1% | +1417.9% |
Matinas BioPharma Holdings Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $11.74 M(-23.2%) |
Jun 2024 | - | $15.29 M(+48.6%) |
Mar 2024 | - | $10.29 M(-33.8%) |
Dec 2023 | $9.56 M(-7.1%) | $15.54 M(-22.2%) |
Sep 2023 | - | $19.99 M(-16.7%) |
Jun 2023 | - | $24.00 M(-14.9%) |
Mar 2023 | - | $28.21 M(-18.3%) |
Dec 2022 | $10.29 M(-0.4%) | $34.53 M(-6.9%) |
Sep 2022 | - | $37.10 M(-11.5%) |
Jun 2022 | - | $41.92 M(-7.1%) |
Mar 2022 | - | $45.12 M(-11.5%) |
Dec 2021 | $10.33 M(+9.8%) | $50.99 M(-9.7%) |
Sep 2021 | - | $56.48 M(-7.3%) |
Jun 2021 | - | $60.94 M(-3.5%) |
Mar 2021 | - | $63.14 M(+2.6%) |
Dec 2020 | $9.41 M(-8.8%) | $61.55 M(-5.6%) |
Sep 2020 | - | $65.20 M(-5.8%) |
Jun 2020 | - | $69.21 M(-6.5%) |
Mar 2020 | - | $73.99 M(+147.3%) |
Dec 2019 | $10.32 M | $29.92 M(-12.6%) |
Sep 2019 | - | $34.25 M(-8.5%) |
Jun 2019 | - | $37.43 M(-6.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $39.90 M(+204.9%) |
Dec 2018 | $6.86 M(+6.2%) | $13.09 M(+73.9%) |
Sep 2018 | - | $7.52 M(-19.5%) |
Jun 2018 | - | $9.34 M(+90.9%) |
Mar 2018 | - | $4.89 M(-38.5%) |
Dec 2017 | $6.46 M(+23.0%) | $7.96 M(-21.7%) |
Sep 2017 | - | $10.17 M(-13.3%) |
Jun 2017 | - | $11.74 M(-30.1%) |
Mar 2017 | - | $16.79 M(+267.8%) |
Dec 2016 | $5.25 M(+8.3%) | $4.57 M(-30.1%) |
Sep 2016 | - | $6.53 M(+744.1%) |
Jun 2016 | - | $773.50 K(-59.5%) |
Mar 2016 | - | $1.91 M(-46.3%) |
Dec 2015 | $4.85 M(+771.3%) | $3.56 M(-27.1%) |
Sep 2015 | - | $4.88 M(-29.0%) |
Jun 2015 | - | $6.88 M(+42.1%) |
Mar 2015 | - | $4.84 M(+72.6%) |
Dec 2014 | $556.30 K(+36.1%) | $2.81 M(-45.2%) |
Sep 2014 | - | $5.11 M(-23.5%) |
Jun 2014 | - | $6.69 M(-22.7%) |
Mar 2014 | - | $8.65 M(-20.9%) |
Dec 2013 | $408.80 K | $10.92 M |
FAQ
- What is Matinas BioPharma Holdings annual total current assets?
- What is the all time high annual current assets for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual current assets year-on-year change?
- What is Matinas BioPharma Holdings quarterly total current assets?
- What is the all time high quarterly current assets for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly current assets year-on-year change?
What is Matinas BioPharma Holdings annual total current assets?
The current annual current assets of MTNB is $15.54 M
What is the all time high annual current assets for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual total current assets is $61.55 M
What is Matinas BioPharma Holdings annual current assets year-on-year change?
Over the past year, MTNB annual total current assets has changed by -$18.99 M (-54.99%)
What is Matinas BioPharma Holdings quarterly total current assets?
The current quarterly current assets of MTNB is $11.74 M
What is the all time high quarterly current assets for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly total current assets is $73.99 M
What is Matinas BioPharma Holdings quarterly current assets year-on-year change?
Over the past year, MTNB quarterly total current assets has changed by -$8.25 M (-41.26%)